TF and carcinoma: Administration of gatipotuzumab (previously known as PankoMab-GEX), a humanized mAb that binds TA-MUC1 in a Tn/TF-dependent manner, was found safe and was well-tolerated in patients with advanced carcinomas, suggesting a potential pan-carcinoma imaging application of the targeting moiety [166].